Santhera Pharmaceuticals Holding Ltd. header image

Santhera Pharmaceuticals Holding Ltd.

SANN

Equity

ISIN CH1276028821 / Valor 127602882

SIX Swiss Exchange (2026-07-31)

CHF 14.16-1.94%

Santhera Pharmaceuticals Holding Ltd.
UMushroom community rating:

5.00 1 votes No rating yet

NegativeNeutralPositive

About company

Santhera Pharmaceuticals Holding Ltd. is a Swiss specialty pharmaceutical company that develops and commercializes therapies for rare neuromuscular, mitochondrial and related pulmonary disorders. Its work has centered on orphan-drug programs — most prominently formulations of idebenone (marketed in some indications) — and clinical development efforts in Duchenne muscular dystrophy and other rare disease indications. The company operates as a typical small-cap biotech, generating revenues from product sales where marketed and from partnerships, milestone and licensing arrangements, while relying on ongoing clinical development, regulatory filings and capital markets financing to advance its pipeline and expand geographic reach.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-4.97%1Y

64.8%3Y

-39.1%5Y

Performance

52.6%1Y

54.2%3Y

66.4%5Y

Volatility

235 M

Market cap (USD)

75,092

Daily traded volume (Shares)

12.7 / 11.56

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

5.00

1 votes

Performance:

5.00

Innovation:

5.00

Society:

5.00

Nature:

5.00

Luba Schoenig

Switzerland, 20 Mar 2025

Ein top innovatives Unternehmen, das sich auf die Behandlung von DMD spezialisiert und seine Marktstellung kontinuierlich ausbaut

EQUITIES OF THE SAME SECTOR

Oxford Nanopore Technologies PLC

Oxford Nanopore Technologies PLC Valor: 23783705

Annual Return

-50%0%+50%

Risk level

110

-0.44%GBP 1.13

Uber Technologies Inc

Uber Technologies Inc Valor: 47459333

Annual Return

-50%0%+50%

Risk level

110

-0.01%USD 70.36

Neurocrine Biosciences Inc

Neurocrine Biosciences Inc Valor: 149044

Annual Return

-50%0%+50%

Risk level

110

-10.08%USD 166.80

Halma PLC

Halma PLC Valor: 387465

Annual Return

-50%0%+50%

Risk level

110

-1.23%GBP 35.30

Rightmove PLC

Rightmove PLC Valor: 42985140

Annual Return

-50%0%+50%

Risk level

110

1.71%GBP 4.65

Bavarian Nordic AS

Bavarian Nordic AS Valor: 944279

Annual Return

-50%0%+50%

Risk level

110

-0.56%DKK 177.90

Edding AG

Edding AG Valor: 331102

Annual Return

-50%0%+50%

Risk level

110

1.49%EUR 41.00

CeoTronics Aktiengesellschaft Audio . Video . Data Communication

CeoTronics Aktiengesellschaft Audio . Video . Data Communication Valor: 942127

Annual Return

-50%0%+50%

Risk level

110

-0.56%EUR 10.60

Qorvo Inc

Qorvo Inc Valor: 25588586

Annual Return

-50%0%+50%

Risk level

110

-0.19%USD 90.57

Magnite Inc

Magnite Inc Valor: 55798557

Annual Return

-50%0%+50%

Risk level

110

-0.46%USD 19.30

SIX

FactSet

Clearbit

Logos provided by Clearbit